The FBMD-1 stroma cell line secretes a unique moiety which can increase retroviral transduction of lineage-committed and primitive human peripheral blood progenitor cells

Cancer Gene Therapy

Volumn 8, Issue 6, 2001, Pages 440-449

  Buss, Eike C ^a   Schiedlmeier, Bernd ^a   Ho, Anthony D ^b   Zeller, W Jens ^a   Fruehauf, Stefan ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

FBMD 1; Gene therapy; Long term culture; MDR1; Peripheral blood progenitor cells (PBPCs); Soluble stroma factors

Indexed keywords

HEPARAN SULFATE; HEPARIN DERIVATIVE;

ADULT; ARTICLE; BLOOD CELL; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RETROVIRUS; STEM CELL; STROMA CELL;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD; CELL LINEAGE; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; FEMALE; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMERASE CHAIN REACTION; RETROVIRIDAE; RHODAMINES; STEM CELLS; STROMAL CELLS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES;

UNIDENTIFIED RETROVIRUS;

EID: 0034886365     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700324     Document Type: Article

References (47)

1. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: Resistance to daunomycin-induced leukopenia
2. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1
3. Introduction of the human MDR1 gene into hematopoietic stem cells to improve cancer chemotherapy
4. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34-selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene
5. Retroviral transfer of human MDR1 gene to hematopoietic cells: Effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein
6. Human multidrug resistance-1 gene transfer to long-term repopulating human mobilized peripheral blood progenitor cells
7. Phase 1 trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem cell transplantation
8. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy
9. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
10. Molecular control of cell cycle progression in primary human hematopoietic stem cells: Methods to increase levels of retroviral-mediated transduction
11. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
12. - cells with preserved ability to engraft SCID-hu bone
13. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands, and RetroNectin culture
14. Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells
15. Adhesion receptors as regulators of the hematopoietic process
16. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation
17. Expression and function of integrins on hematopoietic progenitor cells
18. Stroma-conditioned media improve expansion of human primitive hematopoietic stem cells and progenitor cells
19. + cells
20. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche
21. A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells
22. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: Requirement for optimal binding interactions of heparan sulfate with early acting cytokines and matrix proteins
23. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
24. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: Implications for stem cell frequency assessment
25. Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity
26. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay
27. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells
28. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors
29. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123
30. The parallel groups design
31. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
32. Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: An update on 100 patients
33. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice
34. Quantitative assessment of retroviral transfer of the human multidrug resistance-1 gene to human mobilized peripheral blood progenitor cells engrafting in monobese diabetic/severe combined immunodeficient mice
35. Stroma-conditioned medium and sufficient prestimulation improve fibronectin fragment-mediated retroviral gene transfer into human primitive mobilized peripheral blood stem cells through effects on their recovery and transduction efficiency
36. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
37. + hematopoietic cells
38. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells
39. The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs
40. Improved retroviral transduction of hematopoietic progenitors by combining methods to enhance virus-cell interaction
41. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines
42. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions
43. + cells to fibronectin in an activation-dependent way
44. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophage can function as paracrine regulators of fibroblast growth factor action
45. Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions
46. The V3 region of gp120 is responsible for anti-HIV-1 activity of heparin sulphate
47. Differential inhibition of retrovirus transduction by proteoglycans and free glycosaminoglycans